Technical Analysis for RVPH - Reviva Pharmaceuticals Holdings, Inc.

Grade Last Price % Change Price Change
F 0.98 -12.72% -0.14
RVPH closed down 12.72 percent on Friday, November 1, 2024, on 2.34 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 12
*** please verify all earnings dates ***
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Doji - Bullish? Reversal -12.72%
Stochastic Reached Oversold Weakness -12.72%
Wide Bands Range Expansion -12.72%

   Recent Intraday Alerts

Alert Time
Down 1 ATR about 20 hours ago
2x Volume Pace about 21 hours ago
Fell Below Lower Bollinger Band about 22 hours ago
Lower Bollinger Band Support about 22 hours ago
Down 10% about 22 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Reviva Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops therapies to address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases. Its lead product candidate is RP5063 for the treatment of schizophrenia, bipolar disorder, and major depressive disorder, as well as for treating pulmonary arterial hypertension and idiopathic pulmonary fibrosis. The company is based in Cupertino, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Drugs Inflammatory Diseases Schizophrenia Psychiatric Diagnosis Psychiatry Major Depressive Disorder Stage Pharmaceutical Idiopathic Pulmonary Fibrosis Pulmonary Arterial Hypertension Pulmonary Fibrosis Chloroarenes Bipolar Disorder Pulmonary Hypertension Treatment Of Schizophrenia Piperazines

Is RVPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 6.3001
52 Week Low 0.6
Average Volume 340,175
200-Day Moving Average 2.15
50-Day Moving Average 1.23
20-Day Moving Average 1.21
10-Day Moving Average 1.20
Average True Range 0.13
RSI (14) 35.90
ADX 14.92
+DI 15.67
-DI 26.80
Chandelier Exit (Long, 3 ATRs) 1.13
Chandelier Exit (Short, 3 ATRs) 1.36
Upper Bollinger Bands 1.45
Lower Bollinger Band 0.98
Percent B (%b) 0.0
BandWidth 38.78
MACD Line -0.04
MACD Signal Line 0.00
MACD Histogram -0.0305
Fundamentals Value
Market Cap 27.29 Million
Num Shares 27.9 Million
EPS -1.68
Price-to-Earnings (P/E) Ratio -0.58
Price-to-Sales 0.00
Price-to-Book 69.86
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.26
Resistance 3 (R3) 1.29 1.22 1.22
Resistance 2 (R2) 1.22 1.15 1.21 1.20
Resistance 1 (R1) 1.10 1.10 1.06 1.07 1.18
Pivot Point 1.03 1.03 1.01 1.02 1.03
Support 1 (S1) 0.91 0.96 0.87 0.88 0.77
Support 2 (S2) 0.84 0.91 0.82 0.75
Support 3 (S3) 0.72 0.84 0.74
Support 4 (S4) 0.69